Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhang MR"'
Autor:
Okamura T; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. okamura.toshimitsu@qst.go.jp., Kikuchi T; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Ogawa M; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service, Ltd., 7-1-1 Nishigotanda, Shinagawa-ku, Tokyo, 141-0031, Japan., Zhang MR; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Feb 09; Vol. 9 (1), pp. 10. Date of Electronic Publication: 2024 Feb 09.
Autor:
Ikenuma H; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan., Ogata A; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan.; Department of Pharmacy, Faculty of Pharmacy, Gifu University of Medical Science (GUMS), Kani, Japan., Koyama H; Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan., Ji B; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan.; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.; Department of Radiopharmacy and Molecular Imaging, School of Pharmacy, Fudan University, Shanghai, China., Ishii H; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan.; Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Yamada T; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan., Abe J; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan., Seki C; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan.; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Nagai Y; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Ichise M; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan.; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Minamimoto T; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Higuchi M; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Zhang MR; Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Kato T; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan., Ito K; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan., Suzuki M; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan.; Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan., Kimura Y; Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology (NCGG), 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan. yazkim@ncgg.go.jp.; Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology (QST), Chiba, Japan. yazkim@ncgg.go.jp.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2023 Oct 18; Vol. 8 (1), pp. 31. Date of Electronic Publication: 2023 Oct 18.
Autor:
Kawamura K; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan. kawamura.kazunori@qst.go.jp., Yamasaki T; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan., Fujinaga M; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan., Kokufuta T; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan., Zhang Y; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan., Mori W; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan., Kurihara Y; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd., 7-1-1 Nishigotanda, Shinagawa-Ku, Tokyo, 141-0032, Japan., Ogawa M; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd., 7-1-1 Nishigotanda, Shinagawa-Ku, Tokyo, 141-0032, Japan., Tsukagoe K; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd., 7-1-1 Nishigotanda, Shinagawa-Ku, Tokyo, 141-0032, Japan., Nengaki N; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd., 7-1-1 Nishigotanda, Shinagawa-Ku, Tokyo, 141-0032, Japan., Zhang MR; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2023 Jul 17; Vol. 8 (1), pp. 14. Date of Electronic Publication: 2023 Jul 17.
Autor:
Kiss OC; Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany. o.kiss@hzdr.de., Scott PJH; University of Michigan, Ann Arbor, MI, USA., Behe M; Paul Scherrer Institute, Villigen, Switzerland., Penuelas I; University Clinic of Navarra, Pamplona, Spain., Passchier J; Invicro, Imperial College London, London, UK., Rey A; Universidad de la Rebublica, Montevideo, Uruguay., Patt M; University of Leipzig, Leipzig, Germany., Aime S; University of Torino, Turin, Italy., Jalilian A; IAEA, Vienna, Austria., Laverman P; Radboud University Medical Center, Nijmegen, The Netherlands., Cheng Z; Shanghai Institute of Materia Medica, Shanghai, China., Chauvet AF; Inserm, Nantes, France., Engle J; University of Wisconsin, Madison, WI, USA., Cleeren F; Katholieke Universiteit, Leuven, Belgium., Zhu H; Peking University Cancer Hospital, Beijing, China., Vercouillie J; University of Tours, Tours, France., van Dam M; UCLA, Los Angeles, USA., Zhang MR; NIRS, Chiba, Japan., Perk L; Radboud University Medical Center, Nijmegen, The Netherlands., Guillet B; CERIMED, Marseille, France., Alves F; University of Coimbra, Coimbra, Portugal.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2023 Mar 23; Vol. 8 (1), pp. 6. Date of Electronic Publication: 2023 Mar 23.
Autor:
Bernardes E; IPEN, São Paulo, Brazil., Caravan P; Massuchusetts General Hospital, Harvard University, Cambridge, USA., van Dam RM; University of California, Los Angeles, Los Angeles, USA., Deuther-Conrad W; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Leipzig, Germany. w.deuther-conrad@hzdr.de.; Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany. w.deuther-conrad@hzdr.de., Ellis B; Manchester University NHS Foundation Trust, Manchester, UK., Furumoto S; CYRIC, Tohoku University, Sendai, Japan., Guillet B; CERIMED, C2VN, Aix-Marseille Univ, Marseille, France., Huang YY; National Taiwan University College of Medicine, Taipei, Taiwan., Jia H; Beijing Normal University, Beijing, China., Laverman P; University of Alberta, Edmonton, Canada., Li Z; Xiamen University, Xiamen, China., Liu Z; Peking University, Beijing, China., Lodi F; S. Orsola-Malpighi Hospital, Bologna, Italy., Miao Y; University of Colorado, Denver, USA., Perk L; Radboud University Medical Center, Nijmegen, The Netherlands., Schirrmacher R; University of Alberta, Edmonton, Canada., Vercoullie J; University of Tours, Tours, France., Yang H; TRIUMF, Vancouver, Canada., Yang M; Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, People's Republic of China., Yang X; Peking University First Hospital, Beijing, China., Zhang J; Beijing Normal University, Beijing, China., Zhang MR; NIRS, Chiba, Japan., Zhu H; Peking University Cancer Hospital, Beijing, China.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2022 Apr 26; Vol. 7 (1), pp. 9. Date of Electronic Publication: 2022 Apr 26.
Autor:
Yamasaki T; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Kumata K; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Hiraishi A; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Zhang Y; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Wakizaka H; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Kurihara Y; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Co. Ltd., 1-17-6 Osaki, Shinagawa-ku, Tokyo, 141-0032, Japan., Nengaki N; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Co. Ltd., 1-17-6 Osaki, Shinagawa-ku, Tokyo, 141-0032, Japan., Zhang MR; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. zhang.ming-rong@qst.go.jp.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2022 Mar 15; Vol. 7 (1), pp. 4. Date of Electronic Publication: 2022 Mar 15.
Autor:
Ohkubo T; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan.; SHI Accelerator Service Ltd, 141-0032, Tokyo, Japan., Kurihara Y; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan.; SHI Accelerator Service Ltd, 141-0032, Tokyo, Japan., Ogawa M; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan.; SHI Accelerator Service Ltd, 141-0032, Tokyo, Japan., Nengaki N; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan.; SHI Accelerator Service Ltd, 141-0032, Tokyo, Japan., Fujinaga M; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan., Mori W; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan., Kumata K; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan., Hanyu M; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan., Furutsuka K; SHI Accelerator Service Ltd, 141-0032, Tokyo, Japan., Hashimoto H; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan., Kawamura K; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan. kawamura.kazunori@qst.go.jp., Zhang MR; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555, Chiba, Japan.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2021 Jul 10; Vol. 6 (1), pp. 23. Date of Electronic Publication: 2021 Jul 10.
Autor:
Kawamura K; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. kawamura.kazunori@qst.go.jp., Mori W; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Fujinaga M; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Yamasaki T; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Zhang Y; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Wakizaka H; Department of Medical Physics, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, 263-8555, Japan., Hatori A; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Xie L; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Kumata K; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan., Ohkubo T; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd, Tokyo, 141-0032, Japan., Kurihara Y; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd, Tokyo, 141-0032, Japan., Ogawa M; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd, Tokyo, 141-0032, Japan., Nengaki N; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.; SHI Accelerator Service Ltd, Tokyo, 141-0032, Japan., Zhang MR; Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2019 Feb 18; Vol. 4 (1), pp. 4. Date of Electronic Publication: 2019 Feb 18.